Francis W. Sarena
2017
In 2017, Francis W. Sarena earned a total compensation of $2.8M as Chief Strategy Officer and Secretary at Five Prime Therapeutics, a 34% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,800 |
|---|---|
| Non-Equity Incentive Plan | $192,080 |
| Option Awards | $1,267,839 |
| Salary | $428,099 |
| Stock Awards | $809,859 |
| Other | $6,000 |
| Total | $2,804,677 |
Sarena received $1.3M in option awards, accounting for 45% of the total pay in 2017.
Sarena also received $100.8K in bonus, $192.1K in non-equity incentive plan, $428.1K in salary, $809.9K in stock awards and $6K in other compensation.
Rankings
In 2017, Francis W. Sarena's compensation ranked 3,902nd out of 14,666 executives tracked by ExecPay. In other words, Sarena earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,902 out of 14,666 | 73rd |
Division Manufacturing | 1,366 out of 5,768 | 76th |
Major group Chemicals And Allied Products | 390 out of 2,074 | 81st |
Industry group Drugs | 302 out of 1,730 | 83rd |
Industry Pharmaceutical Preparations | 242 out of 1,329 | 82nd |
Source: SEC filing on March 30, 2018.
Sarena's colleagues
We found four more compensation records of executives who worked with Francis W. Sarena at Five Prime Therapeutics in 2017.